ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Revive Therapeutics Ltd

Revive Therapeutics Ltd (RVV)

0,01
0,005
(100,00%)
Fermé 04 Décembre 10:00PM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
0,01
Prix Achat
0,005
Prix Vente
0,01
Volume échangé
1 437 400
0,01 Fourchette du Jour 0,01
0,005 Plage de 52 semaines 0,04
Clôture Veille
0,005
Ouverture
0,01
Dernière Transaction
30000
@
0.01
Dernière heure de transaction
Volume moyen (3 m)
301 874
Volume financier
-
VWAP
-

RVV Dernières nouvelles

Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19

  Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19   TORONTO, Canada -- April 18, 2022 -- InvestorsHub NewsWire -- Revive...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

  Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19   TORONTO, Canada -- April 12, 2022 -- InvestorsHub NewsWire -- Revive...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19   Expected to seek DSMB approval to proceed with EUA application to the FDA in...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19Ethics Committee approval to proceed with Phase 3 clinical trial in Turkey13 clinical sites selected to...

Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs

 Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs IRB approval to initiate Phase 2 study for methamphetamine abuse disorders Advancing psilocybin oral thin film...

Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19

 Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19 Approximately 700 subjects participated in the enrollment periodExpected to begin subject enrollment...

Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer

  Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer Novel discovery and research originated from Universidad Central del...

Revive Confirms No Material Undisclosed Information

  Revive Confirms No Material Undisclosed Information   Toronto, Ontario, Canada -- August 12, 2021 -- InvestorsHub NewsWire -- Revive Therapeutics Ltd...

Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline

Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline   Focusing on novel uses, production and delivery forms of psilocybin as a next generation solution...

Revive Therapeutics Approved to Trade on the OTCQB Market

 Revive Therapeutics Approved to Trade on the OTCQB Market TORONTO, June 25, 2021 -- InvestorsHub NewsWire -- Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE: RVV, USA: RVVTF, FRANKFURT:...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1000.010.0150.0054173970.00934331CS
4000.010.0150.0053861390.0096415CS
12000.010.0150.0053018740.00883447CS
26-0.015-600.0250.0250.0054666070.01195373CS
52-0.02-66.66666666670.030.040.0053203480.01684607CS
156-0.51-98.07692307690.520.520.0053406520.14246839CS
260-0.02-66.66666666670.030.920.0058668360.31002995CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
USCMUS Critical Metals Corp
$ 0,08
(128,57%)
1,71M
GTOOG2 Energy Corp
$ 0,01
(100,00%)
1 000
WINCommon Stock
$ 0,01
(100,00%)
993k
RVVRevive Therapeutics Ltd
$ 0,01
(100,00%)
1,44M
GHGGlobal Hemp Group Inc
$ 0,02
(100,00%)
13k
OMNDOptimind Pharma Corp
$ 0,005
(-50,00%)
100k
ACRG.A.UAcreage Holdings Inc
US$ 0,005
(-50,00%)
145k
FNQFineqia International Inc
$ 0,005
(-50,00%)
15k
INTGIntegral Metals Corp
$ 0,80
(-33,33%)
500
AITTTrenchant Technologies Capital Corp
$ 0,03
(-33,33%)
6k
SANUSanu Gold Corp
$ 0,10
(0,00%)
2,9M
HPSSHybrid Power Solutions Inc
$ 0,045
(12,50%)
2,47M
BCBCBC Bud Corporation
$ 0,085
(6,25%)
1,94M
USCMUS Critical Metals Corp
$ 0,08
(128,57%)
1,71M
SOLSOL Global Investments Corp
$ 0,22
(0,00%)
1,64M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock